CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction

Cure Pharmaceutical Holding Corp. GlobeNewswire July 28, 2020 MOU to acquire 100% of privately held Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition. Sera Labs brings to CURE a high-margin, retail and direct-to-consumer business…